The Akloma Tinnitus Patch in Patients With Manifested Tinnitus (Aktin)

Investigation of the antinitus patch in patients with manifested tinnitus.

  1. Tinnitus Talk
    Primary Objective The primary objective will be a decrease of inconvenience with at least 10% for at least 50% of the subjects.
    Secondary Objectives
    The secondary objective will be to:
    To evaluate if the patch can improve the tinnitus patient's quality of life and sleep quality.

    Study Design:
    An open safety and performance clinical investigation of the antinitus patch in patients with manifested tinnitus.
    Treatment Duration:
    1 patch per day for 3 weeks
    Primary Endpoint:
    Tinnitus severity questionnaire (TSQ)
    Performance Parameters:
    Tinnitus severity questionnaire (TSQ) and numerical rating scale (NRS) measuring tinnitus annoyance.
    Quality of life and sleep quality
    Safety Parameters: Adverse Reactions

    Estimated Enrollment: 16
    Study Start Date: October 2010
    Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
If you have ringing ears then you've come to the right place. We are a friendly tinnitus support board, dedicated to helping you discuss and understand what tinnitus treatments may work for you.